The Conjugate vaccine is a type of vaccine that contains bacterial capsular polysaccharide, attached to a protein to enhance immunogenicity and protect against invasive diseases. The U.S. is one of the prominent markets for conjugate vaccines.

Scheduled vaccination of conjugate vaccines has eradicated health disparities and consequently, the rate of incidence of diseases in the U.S. have been lower. Native Alaskan/American Indian and African-American children had much higher rates of invasive pneumococcal diseases than white children in the U.S. Vaccination has wiped out these health disparities, and the incidence of these diseases is now relatively low across all groups.

Market Segmentation:

o Based on disease indication, the market is segmented into pneumococcal, haemophilus influenza type b, diphtheria-tetanus-pertussis, meningococcal and others. The highest penetration among paediatrics is that of DTP vaccines.
o Based on end user, the market is segmented into pediatric and adult.

Key growth factors:

The U.S. is projected to be one of the most significant markets for conjugate vaccines during the forecast period, due to a rise in demand for pneumococcal, meningococcal vaccines, and other conjugate vaccines. Increased diagnosis and treatments would fuel the conjugate vaccines market. Recommended vaccines and dosages are updated on a regular basis to comply with prevalent serogroups of infectious agents. For example, the CDC has its own immunization schedule for U.S. citizens. This has increased the effectiveness of administered vaccines, which thereby boosts the demand for the product, leading to increase in market sales. Growing initiatives by HHS to reduce infectious diseases by increasing immunization rates and immunization recommendations will fuel the growth of the market. For instance, the Healthy People 2020 aims for immunization to prevent and treat infectious diseases.

Threats and key players:

o The U.S. conjugate vaccine market is expected to grow positively. But since it is a saturated market, the scope for significant growth is limited. In North America, the population above 65 years of age has decreased from the year 2014 to 2016. So, the demand for adult vaccines has also lowered. The overall penetration rates for the adult segment, is lower than that of the pediatric segment.
o Major conjugate vaccine providers operating in the market are GlaxoSmithKline, Pfizer Inc., Merck, Novartis, Sanofi Pasteur, etc.

What’s covered in the report?

1. Overview of the U.S. conjugate vaccine market
2. Market drivers and challenges in the U.S. conjugate vaccine market
3. Market trends in the U.S. conjugate vaccine market
4. Historical, current and forecasted market size data for the U.S. based on disease indication (pneumococcal, haemophilus influenza type b, diphtheria-tetanus-pertussis, meningococcal conjugate vaccines) – by revenue and by volume
5. Historical, current and forecasted market size data for the U.S. based on the end user (paediatric and adult conjugate vaccines) – by revenue and by volume
6. Analysis of the competitive landscape and profiles of major companies operating in the U.S. market

Why buy?

o Understand the demand for conjugate vaccines to determine the viability of the market
o Develop strategies based on the drivers and trends for each of the segments
o Evaluate the value chain to determine the workflow and to get an idea of the current position where you are placed
o Recognize the key competitors of this market and respond accordingly
o Identify the initiatives and growth strategies taken up by the major companies and decide on the direction for further growth
o Define the competitive positioning by comparing the products and services with the key players in the market

Chapter 1: Executive Summary
1.1 Market Scope and Segmentation
1.2 Key Questions Answered in This Study
1.3 Executive Summary I
1.4 Executive Summary II

Chapter 2: Introduction
2.1. Blockchain technology-Functionality
2.2. Blockchain Application
2.3. Blockchain use cases
2.4. Value chain-Blockchain technology market

Chapter 3: Global Blockchain Technology Market overview
3.1. Overview – key observations, historical (2016-2017) and forecasted (2018-2023) market size (USD bn), geography wise market size (USD bn) in 2017
3.2. Market adoption
3.3. Market trends

Chapter 4: Blockchain Technology Market regional market overview
4.1. North America- Historical (2016-2017) and forecasted (2018-2023) market size (USD Bn), drivers, trends and challenges
4.2. Europe– Historical (2016-2017) and forecasted (2018-2023) market size (USD Bn), drivers, trends and challenges
4.3. Asia Pacific– Historical (2016-2017) and forecasted (2018-2023) market size (USD Bn), drivers, trends and challenges
4.4. Latin America– Historical (2016-2017) and forecasted (2018-2023) market size (USD Bn), drivers, trends and challenges
4.5. Middle East & Africa– Historical (2016-2017) and forecasted (2018-2023) market size (USD Bn), drivers, trends and challenges

Chapter 5: Blockchain Technology Market segmentation by industries
5.1. Global industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Industry overview, market share
5.1.1. North America industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Revenue contribution (historical and forecasted), drivers, and key competitors
5.1.2. Europe industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Revenue contribution (historical and forecasted), drivers, and key competitors
5.1.3. Asia Pacific industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Revenue contribution (historical and forecasted), drivers, and key competitors
5.1.4. Latin America industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Revenue contribution (historical and forecasted), drivers, and key competitors
5.1.5. Middle East & Africa industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Revenue contribution (historical and forecasted), drivers, and key competitors

Chapter 6: Blockchain Technology Market segmentation by type – Private, public and mixed
6.1. Market overview by type – revenue contribution, market growth, influential factors, adoption

Chapter 7: Patent Analysis
7.1. Patent Overview
7.2. Patents Filed/ Published (2012 – 2016)
7.3. Patents by Major Companies
7.4. Patents by Geographical Origin
7.5. Patents by Platform
7.6. Patents by Ledger Types
7.7. Patents by Authentication
7.8. Patents by Application types

Chapter 8: Company Profiles
8.1. Microsoft Corporation
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.2. IBM
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.3. Accenture
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.4. Deloitte
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.5. Capgemini
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.6. Cognizant
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.7. Infosys
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.8. Tata Communication Services
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.9. VirtusaPolaris
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.10. Wipro
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence

Chapter 9: Start-up Company Overview
9.1. Chain (*)
o Overview
o Key People
o Investor
o Client/Partners
o Recent Initiatives
(*) similar information is provided for all the below companies
9.2. Consensys
9.3. R3 CEV
9.4. Ripple
9.5. Guardtime
9.6. Gem
9.7. Everledger
9.8. Ascribe

Chapter 10: Conclusion
10.1. Blockchain Opportunity
10.2. Conclusion

Chapter 11: Appendix
11.1. List of Tables
11.2. Research Methodology
11.3. Assumptions
11.4. About Netscribes Inc.

The post The U.S. Conjugate Vaccine Market (2018-2023) first appeared on CRI Report.

Conjugate vaccine is a type of vaccine that contains bacterial capsular polysaccharide, attached with a protein to enhance immunogenicity and protect against invasive diseases. North America is one of the most prominent markets for conjugate vaccines. The conjugate vaccine market in North America is expected to expand at a CAGR of 3.2%, leading to a revenue of USD 16.26 Bn by 2023. By volume, it is anticipated to reach 286.63 Million units by 2023 expanding at a CAGR of 3%.

Scheduled conjugated vaccinations, have eradicated health disparities and consequently led to lower rate of disease incidence.

Market Segmentation:

o Based on disease indication, the market is segmented into pneumococcal, haemophilus influenza type b, diphtheria-tetanus-pertussis, meningococcal and others. The highest penetration among paediatrics in North America was in the case of DTP vaccines.
o Based on end user, the market is segmented into pediatric and adult.
o Based on countries, the market is divided into U.S. and Canada.

Key growth factors:

North America is projected to be one of the most significant markets for conjugate vaccines during the forecast period, due to a rise in demand for pneumococcal, meningococcal vaccines, and other conjugate vaccines. Increased diagnosis and treatment are considered to fuel the North American conjugate vaccine market. Recommended vaccines and dosages are updated on a regular basis to comply with prevalent serogroups of infectious agents. For example, the CDC has its own immunization schedule for US citizens. This has increased the effectiveness of administered vaccines, which thereby increases the demand for the product, leading to increase in market sales.

Threats and key players:

o The North America conjugate vaccine market is expected to grow positively. But since it is a saturated market, the scope for significant growth is limited. In North America, the population above 65 years of age has decreased from 53,000,000 in 2014 to 51,900,000 in 2016. So, the demand for adult vaccines has also reduced. The overall penetration rate for the adult segment is lower than that of the pediatric segment.
o Major conjugate vaccine providers operating in the market are GlaxoSmithKline, Pfizer Inc., Merck, Novartis, Sanofi Pasteur, etc.

What’s covered in the report?

1. Overview of the North America conjugate vaccine market
2. Market drivers and challenges in the North America conjugate vaccine market
3. Market trends in the North America conjugate vaccine market
4. Historical, current and forecasted market size data for North America based on disease indication (pneumococcal, haemophilus influenza type b, diphtheria-tetanus-pertussis, meningococcal conjugate vaccines) – by revenue and by volume
5. Historical, current and forecasted market size data for North America based on end user (pediatric and adult conjugate vaccines) – by revenue and by volume
6. Historical, current and forecasted market size data of conjugate vaccines by countries (U.S., Canada) – by revenue and by volume
7. Historical, current and forecasted market size data for country-wise segments – by revenue and by volume
8. Analysis of the competitive landscape and profiles of major companies operating in the North American market

Why buy?

o Understand the demand for conjugate vaccines to determine the viability of the market
o Understand the country-specific market size and observations for each segment
o Develop strategies based on the drivers, trends and highlights for each of the segments
o Evaluate the value chain to determine the workflow and to get an idea of the current position where you are placed
o Recognize the key competitors of this market and respond accordingly
o Identify the initiatives and growth strategies taken up by the major companies and decide on the direction for further growth
o Define the competitive positioning by comparing the products and services with the key players in the market

Chapter 1: Executive Summary
1.1 Market Scope and Segmentation
1.2 Key Questions Answered in This Study
1.3 Executive Summary I
1.4 Executive Summary II

Chapter 2: Introduction
2.1. Blockchain technology-Functionality
2.2. Blockchain Application
2.3. Blockchain use cases
2.4. Value chain-Blockchain technology market

Chapter 3: Global Blockchain Technology Market overview
3.1. Overview – key observations, historical (2016-2017) and forecasted (2018-2023) market size (USD bn), geography wise market size (USD bn) in 2017
3.2. Market adoption
3.3. Market trends

Chapter 4: Blockchain Technology Market regional market overview
4.1. North America- Historical (2016-2017) and forecasted (2018-2023) market size (USD Bn), drivers, trends and challenges
4.2. Europe– Historical (2016-2017) and forecasted (2018-2023) market size (USD Bn), drivers, trends and challenges
4.3. Asia Pacific– Historical (2016-2017) and forecasted (2018-2023) market size (USD Bn), drivers, trends and challenges
4.4. Latin America– Historical (2016-2017) and forecasted (2018-2023) market size (USD Bn), drivers, trends and challenges
4.5. Middle East & Africa– Historical (2016-2017) and forecasted (2018-2023) market size (USD Bn), drivers, trends and challenges

Chapter 5: Blockchain Technology Market segmentation by industries
5.1. Global industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Industry overview, market share
5.1.1. North America industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Revenue contribution (historical and forecasted), drivers, and key competitors
5.1.2. Europe industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Revenue contribution (historical and forecasted), drivers, and key competitors
5.1.3. Asia Pacific industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Revenue contribution (historical and forecasted), drivers, and key competitors
5.1.4. Latin America industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Revenue contribution (historical and forecasted), drivers, and key competitors
5.1.5. Middle East & Africa industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Revenue contribution (historical and forecasted), drivers, and key competitors

Chapter 6: Blockchain Technology Market segmentation by type – Private, public and mixed
6.1. Market overview by type – revenue contribution, market growth, influential factors, adoption

Chapter 7: Patent Analysis
7.1. Patent Overview
7.2. Patents Filed/ Published (2012 – 2016)
7.3. Patents by Major Companies
7.4. Patents by Geographical Origin
7.5. Patents by Platform
7.6. Patents by Ledger Types
7.7. Patents by Authentication
7.8. Patents by Application types

Chapter 8: Company Profiles
8.1. Microsoft Corporation
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.2. IBM
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.3. Accenture
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.4. Deloitte
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.5. Capgemini
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.6. Cognizant
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.7. Infosys
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.8. Tata Communication Services
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.9. VirtusaPolaris
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.10. Wipro
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence

Chapter 9: Start-up Company Overview
9.1. Chain (*)
o Overview
o Key People
o Investor
o Client/Partners
o Recent Initiatives
(*) similar information is provided for all the below companies
9.2. Consensys
9.3. R3 CEV
9.4. Ripple
9.5. Guardtime
9.6. Gem
9.7. Everledger
9.8. Ascribe

Chapter 10: Conclusion
10.1. Blockchain Opportunity
10.2. Conclusion

Chapter 11: Appendix
11.1. List of Tables
11.2. Research Methodology
11.3. Assumptions
11.4. About Netscribes Inc.

The post North America Conjugate Vaccine Market (2018-2023) first appeared on CRI Report.

Conjugate vaccine is a type of vaccine that contains bacterial capsular polysaccharide, attached to a protein to enhance immunogenicity and protect against invasive diseases. Latin America is a market with a significant growth rate for conjugate vaccines. The conjugate vaccine market in Latin America is expected to grow at a CAGR of 20.4% leading to revenue of USD 5.43 Bn by 2023. By volume, it is anticipated to reach 839.21 Million units by 2023, expanding at a CAGR of 20.19%.

Countries in the Americas have been among the first few developing nations to introduce pneumococcal conjugate vaccines into their Expanded Programs on Immunization, with 34 countries and territories having introduced these vaccines as of September 2015.

Market Segmentation:

o Based on disease indication, the market is segmented into pneumococcal, haemophilus influenza type B, diphtheria-tetanus-pertussis, meningococcal and others.
o Based on end user, the market is segmented into paediatric and adult.
o By countries, the Latin American market is divided into Brazil, Argentina and the Rest of LATAM.

Key growth factors:

Latin America has a growing market owing to increase in the incidence of chronic diseases, government initiatives, and control strategies.

Threats and key players:

o The Latin America Conjugate Vaccine market is expected to grow positively. There are still a lot of gaps to be filled for a higher penetration of such vaccines among the masses. A dearth of data on Hib disease burden and limited awareness of Hib disease has resulted in a lack of advocacy for the introduction of Hib vaccine in some countries. Highly complicated manufacturing processes, pricing inefficiencies and lack of accessibility are some of the major obstacles in the growth path, which need to be addressed.
o Conjugate Vaccine providers operating in the market are Pfizer Inc., Merck, Novartis, Sanofi Pasteur, CSL Limited, etc.

What’s covered in the report?

1. Overview of the Latin America conjugate vaccine market
2. Market drivers, and challenges in the Latin America conjugate vaccine market
3. Market trends in Latin America conjugate vaccine market
4. Historical, current and forecasted market size data for Latin America based on disease indication (pneumococcal, haemophilus influenza type b, diphtheria-tetanus-pertussis, meningococcal conjugate vaccines) – by revenue and by volume
5. Historical, current and forecasted market size data for Latin America by end user (paediatric and adult conjugate vaccines) – by revenue and by volume
6. Historical, current and forecasted market size data of conjugate vaccines by countries (Brazil, Argentina and the Rest of LATAM) – by revenue and by volume
7. Historical, current and forecasted market size data for country-wise segments – by revenue and by volume
8. Analysis of the competitive landscape and profiles of major competitors operating in the Latin American market

Why buy?

o Understand the demand for conjugate vaccines to determine the viability of the market
o Understand the country-specific market size and observations for each segment
o Develop strategies based on the drivers, trends and highlights for each of the segments
o Evaluate the value chain to determine the workflow and to get an idea of the current position where you are placed
o Recognize the key competitors of this market and respond accordingly
o Identify the initiatives and growth strategies taken up by the major companies and decide on the direction for further growth
o Define the competitive positioning by comparing the products and services with the key players in the market

:

Chapter 1: Executive Summary
1.1 Market Scope and Segmentation
1.2 Key Questions Answered in This Study
1.3 Executive Summary I
1.4 Executive Summary II

Chapter 2: Introduction
2.1. Blockchain technology-Functionality
2.2. Blockchain Application
2.3. Blockchain use cases
2.4. Value chain-Blockchain technology market

Chapter 3: Global Blockchain Technology Market overview
3.1. Overview – key observations, historical (2016-2017) and forecasted (2018-2023) market size (USD bn), geography wise market size (USD bn) in 2017
3.2. Market adoption
3.3. Market trends

Chapter 4: Blockchain Technology Market regional market overview
4.1. North America- Historical (2016-2017) and forecasted (2018-2023) market size (USD Bn), drivers, trends and challenges
4.2. Europe– Historical (2016-2017) and forecasted (2018-2023) market size (USD Bn), drivers, trends and challenges
4.3. Asia Pacific– Historical (2016-2017) and forecasted (2018-2023) market size (USD Bn), drivers, trends and challenges
4.4. Latin America– Historical (2016-2017) and forecasted (2018-2023) market size (USD Bn), drivers, trends and challenges
4.5. Middle East & Africa– Historical (2016-2017) and forecasted (2018-2023) market size (USD Bn), drivers, trends and challenges

Chapter 5: Blockchain Technology Market segmentation by industries
5.1. Global industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Industry overview, market share
5.1.1. North America industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Revenue contribution (historical and forecasted), drivers, and key competitors
5.1.2. Europe industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Revenue contribution (historical and forecasted), drivers, and key competitors
5.1.3. Asia Pacific industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Revenue contribution (historical and forecasted), drivers, and key competitors
5.1.4. Latin America industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Revenue contribution (historical and forecasted), drivers, and key competitors
5.1.5. Middle East & Africa industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Revenue contribution (historical and forecasted), drivers, and key competitors

Chapter 6: Blockchain Technology Market segmentation by type – Private, public and mixed
6.1. Market overview by type – revenue contribution, market growth, influential factors, adoption

Chapter 7: Patent Analysis
7.1. Patent Overview
7.2. Patents Filed/ Published (2012 – 2016)
7.3. Patents by Major Companies
7.4. Patents by Geographical Origin
7.5. Patents by Platform
7.6. Patents by Ledger Types
7.7. Patents by Authentication
7.8. Patents by Application types

Chapter 8: Company Profiles
8.1. Microsoft Corporation
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.2. IBM
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.3. Accenture
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.4. Deloitte
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.5. Capgemini
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.6. Cognizant
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.7. Infosys
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.8. Tata Communication Services
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.9. VirtusaPolaris
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.10. Wipro
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence

Chapter 9: Start-up Company Overview
9.1. Chain (*)
o Overview
o Key People
o Investor
o Client/Partners
o Recent Initiatives
(*) similar information is provided for all the below companies
9.2. Consensys
9.3. R3 CEV
9.4. Ripple
9.5. Guardtime
9.6. Gem
9.7. Everledger
9.8. Ascribe

Chapter 10: Conclusion
10.1. Blockchain Opportunity
10.2. Conclusion

Chapter 11: Appendix
11.1. List of Tables
11.2. Research Methodology
11.3. Assumptions
11.4. About Netscribes Inc.

The post Latin America Conjugate Vaccine Market (2018-2023) first appeared on CRI Report.

Conjugate Vaccine is a type of vaccine that contains bacterial capsular polysaccharide, attached to a protein to enhance immunogenicity and protects against invasive diseases. Japan is one of the most prominent markets of conjugate vaccines.

Japan, at 84 years, has one of the highest life expectancies in the world. Currently, both PPSV–23 and PCV–13 are available for the elderly for the prevention of Streptococcus pneumoniae -related diseases. Despite these two vaccines being made available for the elderly, the national immunization program launched for these aged 65 and older as on October 1, 2014, only subsidized PPSV–23. Japan has frequently reported low incidence of Meningococcal disease, and therefore the disease is not considered a high health care priority.

Market Segmentation:

Based on disease indication, the market is segmented into:
o Pneumococcal
o Haemophilus influenza type b
o Diphtheria-tetanus-pertussis
o Meningococcal
o Others

Based on end user, the market is segmented into:
o Paediatric
o Adult

Key growth factors:

Japan is projected to be a stable market for conjugate vaccines during the forecast period. Rapidly increasing geriatric population, rise in consumer awareness, growing disposable income and healthcare expenditure and modernization of healthcare infrastructure will drive the Japan market for conjugate vaccines. Japan, with the highest life expectancy out of all other countries in the world, has its old population creating demand for adult conjugate vaccines.

Threats and key players:

1. Although the health situation in Japan is among the best in the world, there is still a significant gap to be filled, with regard to the use of vaccines to prevent severe infections. This gap has major implications for public health, both in Japan and other countries since Japan is cited as a source for infectious diseases to countries that have those diseases under better control through vaccination. There is also a need to organize an efficient immunization program, due to the limited resources for health care. Under-reporting, lack of awareness and focus on meningococcal disease are some of the major threats.

2. Major conjugate vaccine providers are GlaxoSmithKline, Pfizer Inc., Merck, Novartis, Sanofi Pasteur, etc.

What’s covered in the report?

1. Overview of the Japan conjugate vaccine market
2. Market drivers and challenges in the Japan conjugate vaccine market
3. Market trends in the Japan conjugate vaccine market
4. Historical, current and forecasted market size data for Japan based on disease indication (pneumococcal, haemophilus influenza type b, diphtheria-tetanus-pertussis, meningococcal conjugate vaccines) – by revenue and by volume
5. Historical, current and forecasted market size data for Japan based on end user (paediatric and adult conjugate vaccines) – by revenue and by volume
6. Analysis of the competitive landscape and profiles of major companies operating in the Japan market

Why buy?

o Understand the demand for conjugate vaccines to determine the viability of the market
o Develop strategies based on the drivers and trends for each of the segments
o Evaluate the value chain to determine the workflow and to get an idea of the current position where you are placed
o Recognize the key competitors of this market and respond accordingly
o Identify the initiatives and growth strategies taken up by the major companies and decide on the direction for further growth
o Define the competitive positioning by comparing the products and services with the key players in the market

Chapter 1: Executive Summary
1.1 Market Scope and Segmentation
1.2 Key Questions Answered in This Study
1.3 Executive Summary I
1.4 Executive Summary II

Chapter 2: Introduction
2.1. Blockchain technology-Functionality
2.2. Blockchain Application
2.3. Blockchain use cases
2.4. Value chain-Blockchain technology market

Chapter 3: Global Blockchain Technology Market overview
3.1. Overview – key observations, historical (2016-2017) and forecasted (2018-2023) market size (USD bn), geography wise market size (USD bn) in 2017
3.2. Market adoption
3.3. Market trends

Chapter 4: Blockchain Technology Market regional market overview
4.1. North America- Historical (2016-2017) and forecasted (2018-2023) market size (USD Bn), drivers, trends and challenges
4.2. Europe– Historical (2016-2017) and forecasted (2018-2023) market size (USD Bn), drivers, trends and challenges
4.3. Asia Pacific– Historical (2016-2017) and forecasted (2018-2023) market size (USD Bn), drivers, trends and challenges
4.4. Latin America– Historical (2016-2017) and forecasted (2018-2023) market size (USD Bn), drivers, trends and challenges
4.5. Middle East & Africa– Historical (2016-2017) and forecasted (2018-2023) market size (USD Bn), drivers, trends and challenges

Chapter 5: Blockchain Technology Market segmentation by industries
5.1. Global industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Industry overview, market share
5.1.1. North America industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Revenue contribution (historical and forecasted), drivers, and key competitors
5.1.2. Europe industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Revenue contribution (historical and forecasted), drivers, and key competitors
5.1.3. Asia Pacific industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Revenue contribution (historical and forecasted), drivers, and key competitors
5.1.4. Latin America industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Revenue contribution (historical and forecasted), drivers, and key competitors
5.1.5. Middle East & Africa industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Revenue contribution (historical and forecasted), drivers, and key competitors

Chapter 6: Blockchain Technology Market segmentation by type – Private, public and mixed
6.1. Market overview by type – revenue contribution, market growth, influential factors, adoption

Chapter 7: Patent Analysis
7.1. Patent Overview
7.2. Patents Filed/ Published (2012 – 2016)
7.3. Patents by Major Companies
7.4. Patents by Geographical Origin
7.5. Patents by Platform
7.6. Patents by Ledger Types
7.7. Patents by Authentication
7.8. Patents by Application types

Chapter 8: Company Profiles
8.1. Microsoft Corporation
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.2. IBM
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.3. Accenture
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.4. Deloitte
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.5. Capgemini
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.6. Cognizant
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.7. Infosys
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.8. Tata Communication Services
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.9. VirtusaPolaris
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.10. Wipro
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence

Chapter 9: Start-up Company Overview
9.1. Chain (*)
o Overview
o Key People
o Investor
o Client/Partners
o Recent Initiatives
(*) similar information is provided for all the below companies
9.2. Consensys
9.3. R3 CEV
9.4. Ripple
9.5. Guardtime
9.6. Gem
9.7. Everledger
9.8. Ascribe

Chapter 10: Conclusion
10.1. Blockchain Opportunity
10.2. Conclusion

Chapter 11: Appendix
11.1. List of Tables
11.2. Research Methodology
11.3. Assumptions
11.4. About Netscribes Inc.

The post Japan Conjugate Vaccine Market (2018-2023) first appeared on CRI Report.

Conjugate vaccine is a type of vaccine that contains bacterial capsular polysaccharide, attached to a protein to enhance immunogenicity and protects against invasive diseases. India is one of the most prominent markets of conjugate vaccines.

India is expected to be the fastest growing market due to the government’s focus on research and development in the life sciences domain. By making Pneumococcal Conjugate Vaccine (PCV) available under the Universal immunization program (UIP), the government of India is ensuring equitable access to those who need them the most – the underprivileged and underserved. Hib is one of the leading causes of bacterial meningitis in India and a major cause of childhood pneumonia. The introduction of LPV in India is a significant milestone and a step forward towards accelerating child survival in India, and progress towards achieving national health goals and the Millennium Development Goal 4.

Market Segmentation:

o Based on disease indication, the market is segmented into pneumococcal, haemophilus influenza type b, diphtheria-tetanus-pertussis, meningococcal and others.
o Based on end user, the market is segmented into paediatric and adult.

Key growth factors:

India is projected to be the fastest growing market for conjugate vaccines during the forecast period. Rapidly increasing population, rise in consumer awareness, growing disposable income and healthcare expenditure, modernization of healthcare infrastructure, and a growing medical tourism industry will drive the growth of the Indian market.

Threats and key players:

o The India conjugate vaccine market is expected to have significantly high growth. Delayed introduction of conjugate vaccines is likely to hold back the conjugate vaccine market. Though the prevalence of chronic diseases is high, limited availability and accessibility of conjugate vaccines in remote areas can become a cause for concern. Complicated manufacturing can also be a major restraint for this market.
o Major conjugate vaccine providers operating in the market are GlaxoSmithKline, Pfizer Inc., Merck, Novartis, Sanofi Pasteur, etc.

What’s covered in the report?

1. Overview of the India conjugate vaccine market
2. Market drivers and challenges in the India conjugate vaccine market
3. Market trends in India conjugate vaccine market
4. Historical, current and forecasted market size data for India based on disease indication (pneumococcal, haemophilus influenza type b, diphtheria-tetanus-pertussis, meningococcal conjugate vaccines) – by revenue and by volume
5. Historical, current and forecasted market size data for India based on end user (paediatric and adult conjugate vaccines) – by revenue and by volume
6. Analysis of the competitive landscape and profiles of major companies operating in the Indian market

Why buy?

o Understand the demand for conjugate vaccines to determine the viability of the market
o Develop strategies based on the drivers and trends for each of the segments
o Evaluate the value chain to define the workflow and to get an idea of the current position where you are placed
o Recognize the key competitors of this market and respond accordingly
o Identify the initiatives and growth strategies taken up by the major companies and decide on the direction for further growth
o Define the competitive positioning by comparing the products and services with the key players in the market

Chapter 1: Executive Summary
1.1 Market Scope and Segmentation
1.2 Key Questions Answered in This Study
1.3 Executive Summary I
1.4 Executive Summary II

Chapter 2: Introduction
2.1. Blockchain technology-Functionality
2.2. Blockchain Application
2.3. Blockchain use cases
2.4. Value chain-Blockchain technology market

Chapter 3: Global Blockchain Technology Market overview
3.1. Overview – key observations, historical (2016-2017) and forecasted (2018-2023) market size (USD bn), geography wise market size (USD bn) in 2017
3.2. Market adoption
3.3. Market trends

Chapter 4: Blockchain Technology Market regional market overview
4.1. North America- Historical (2016-2017) and forecasted (2018-2023) market size (USD Bn), drivers, trends and challenges
4.2. Europe– Historical (2016-2017) and forecasted (2018-2023) market size (USD Bn), drivers, trends and challenges
4.3. Asia Pacific– Historical (2016-2017) and forecasted (2018-2023) market size (USD Bn), drivers, trends and challenges
4.4. Latin America– Historical (2016-2017) and forecasted (2018-2023) market size (USD Bn), drivers, trends and challenges
4.5. Middle East & Africa– Historical (2016-2017) and forecasted (2018-2023) market size (USD Bn), drivers, trends and challenges

Chapter 5: Blockchain Technology Market segmentation by industries
5.1. Global industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Industry overview, market share
5.1.1. North America industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Revenue contribution (historical and forecasted), drivers, and key competitors
5.1.2. Europe industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Revenue contribution (historical and forecasted), drivers, and key competitors
5.1.3. Asia Pacific industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Revenue contribution (historical and forecasted), drivers, and key competitors
5.1.4. Latin America industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Revenue contribution (historical and forecasted), drivers, and key competitors
5.1.5. Middle East & Africa industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Revenue contribution (historical and forecasted), drivers, and key competitors

Chapter 6: Blockchain Technology Market segmentation by type – Private, public and mixed
6.1. Market overview by type – revenue contribution, market growth, influential factors, adoption

Chapter 7: Patent Analysis
7.1. Patent Overview
7.2. Patents Filed/ Published (2012 – 2016)
7.3. Patents by Major Companies
7.4. Patents by Geographical Origin
7.5. Patents by Platform
7.6. Patents by Ledger Types
7.7. Patents by Authentication
7.8. Patents by Application types

Chapter 8: Company Profiles
8.1. Microsoft Corporation
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.2. IBM
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.3. Accenture
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.4. Deloitte
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.5. Capgemini
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.6. Cognizant
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.7. Infosys
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.8. Tata Communication Services
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.9. VirtusaPolaris
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.10. Wipro
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence

Chapter 9: Start-up Company Overview
9.1. Chain (*)
o Overview
o Key People
o Investor
o Client/Partners
o Recent Initiatives
(*) similar information is provided for all the below companies
9.2. Consensys
9.3. R3 CEV
9.4. Ripple
9.5. Guardtime
9.6. Gem
9.7. Everledger
9.8. Ascribe

Chapter 10: Conclusion
10.1. Blockchain Opportunity
10.2. Conclusion

Chapter 11: Appendix
11.1. List of Tables
11.2. Research Methodology
11.3. Assumptions
11.4. About Netscribes Inc.

The post India Conjugate Vaccine Market (2018-2023) first appeared on CRI Report.

Conjugate vaccine is a type of vaccine that contains bacterial capsular polysaccharide, attached to a protein to enhance immunogenicity and protect against invasive diseases. The global conjugate vaccine market is expected to grow at a CAGR of 14.6%, leading to a global revenue of USD 100.59 Bn by 2023. By volume, it is anticipated to reach 9600.56 Million units by 2023, expanding at a CAGR of 17.2%.

The conjugate vaccine market is classified into two primary segments-based on disease indication: pneumococcal, haemophilus influenza type b, diphtheria-tetanus-pertussis, meningococcal and others; and based on end user: paediatric and adult. Asia-Pacific will have the highest CAGR during the forecasted period.

Key growth factors:

o Rising adoption of cancer therapeutic vaccines, improvement in patient compliance along with an increasing product pipeline, and growing efforts for the adoption of appropriate preventive screening methods to help avert adverse reactions will accelerate the market.
o Conjugate Vaccine market is expected to have positive growth owing to technological advancements, growth initiatives for the production of low-cost vaccines, and widespread routine vaccination programs in emerging economies.

Threats and key players:
o Although the conjugate vaccine market is expected to have a positive growth globally, lack of awareness, shortage risk, the situation of oligopoly, uncertainty about the future of international initiatives, emerging manufacturers, and costs and prices of new vaccines will hinder growth.
o Major Conjugate Vaccine providers operating in the market are GlaxoSmithKline, Pfizer Inc., Sanofi Pasteur, Novartis, etc.

What’s covered in the report?

1. Overview of the global conjugate vaccine market
2. Market drivers and challenges in the global conjugate vaccine market
3. Market trends in the global conjugate vaccine market
4. Historical, current and forecasted market size data for the global disease indication segment (pneumococcal, haemophilus influenza type b, diphtheria-tetanus-pertussis, meningococcal conjugate vaccines) – by revenue and by volume
5. Historical, current and forecasted market size data for the global end user segment (paediatric and adult conjugate vaccines) – by revenue and by volume
6. Historical, current and forecasted regional (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) market size data for the conjugate vaccine market – by revenue and by volume
7. Historical, current and forecasted market size data for the region-wise conjugate vaccine market segments – by revenue and by volume
8. Analysis of the competitive landscape and profiles of major companies operating in the market

Why buy?

o Understand the demand for conjugate vaccines to determine the viability of the market
o Determine the developed and emerging markets where conjugate vaccines are provided
o Identify the challenge areas and address them
o Develop strategies based on the drivers, trends and highlights for each of the segments
o Evaluate the value chain to determine the workflow and to get an idea of the current position where you are placed
o Recognize the key competitors of this market and respond accordingly
o Knowledge of the initiatives and growth strategies taken up by the major companies and decide on the direction for further growth
o Define the competitive positioning by comparing the products and services with the key players in the market

Chapter 1: Executive Summary
1.1 Market Scope and Segmentation
1.2 Key Questions Answered in This Study
1.3 Executive Summary I
1.4 Executive Summary II

Chapter 2: Introduction
2.1. Blockchain technology-Functionality
2.2. Blockchain Application
2.3. Blockchain use cases
2.4. Value chain-Blockchain technology market

Chapter 3: Global Blockchain Technology Market overview
3.1. Overview – key observations, historical (2016-2017) and forecasted (2018-2023) market size (USD bn), geography wise market size (USD bn) in 2017
3.2. Market adoption
3.3. Market trends

Chapter 4: Blockchain Technology Market regional market overview
4.1. North America- Historical (2016-2017) and forecasted (2018-2023) market size (USD Bn), drivers, trends and challenges
4.2. Europe– Historical (2016-2017) and forecasted (2018-2023) market size (USD Bn), drivers, trends and challenges
4.3. Asia Pacific– Historical (2016-2017) and forecasted (2018-2023) market size (USD Bn), drivers, trends and challenges
4.4. Latin America– Historical (2016-2017) and forecasted (2018-2023) market size (USD Bn), drivers, trends and challenges
4.5. Middle East & Africa– Historical (2016-2017) and forecasted (2018-2023) market size (USD Bn), drivers, trends and challenges

Chapter 5: Blockchain Technology Market segmentation by industries
5.1. Global industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Industry overview, market share
5.1.1. North America industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Revenue contribution (historical and forecasted), drivers, and key competitors
5.1.2. Europe industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Revenue contribution (historical and forecasted), drivers, and key competitors
5.1.3. Asia Pacific industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Revenue contribution (historical and forecasted), drivers, and key competitors
5.1.4. Latin America industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Revenue contribution (historical and forecasted), drivers, and key competitors
5.1.5. Middle East & Africa industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Revenue contribution (historical and forecasted), drivers, and key competitors

Chapter 6: Blockchain Technology Market segmentation by type – Private, public and mixed
6.1. Market overview by type – revenue contribution, market growth, influential factors, adoption

Chapter 7: Patent Analysis
7.1. Patent Overview
7.2. Patents Filed/ Published (2012 – 2016)
7.3. Patents by Major Companies
7.4. Patents by Geographical Origin
7.5. Patents by Platform
7.6. Patents by Ledger Types
7.7. Patents by Authentication
7.8. Patents by Application types

Chapter 8: Company Profiles
8.1. Microsoft Corporation
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.2. IBM
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.3. Accenture
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.4. Deloitte
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.5. Capgemini
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.6. Cognizant
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.7. Infosys
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.8. Tata Communication Services
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.9. VirtusaPolaris
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.10. Wipro
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence

Chapter 9: Start-up Company Overview
9.1. Chain (*)
o Overview
o Key People
o Investor
o Client/Partners
o Recent Initiatives
(*) similar information is provided for all the below companies
9.2. Consensys
9.3. R3 CEV
9.4. Ripple
9.5. Guardtime
9.6. Gem
9.7. Everledger
9.8. Ascribe

Chapter 10: Conclusion
10.1. Blockchain Opportunity
10.2. Conclusion

Chapter 11: Appendix
11.1. List of Tables
11.2. Research Methodology
11.3. Assumptions
11.4. About Netscribes Inc.

The post Global Conjugate Vaccine Market (2018-2023) first appeared on CRI Report.

Conjugate vaccine is a type of vaccine that contains bacterial capsular polysaccharide, attached with a protein to enhance immunogenicity and protect against invasive diseases. Europe is a market with stable growth for conjugate vaccines. The conjugate vaccine market in Europe is expected to expand at a CAGR of 3.6% leading to a revenue of USD 8.94 Bn by 2023. By volume, it is anticipated to reach 504.46 Million units by 2023, expanding at a CAGR of 3.7%.

The U.K. was the first country to introduce MenB-4C into their National Infant Immunization Program (2015). In all EU/EEA countries, Hib vaccination has been part of the immunization programs, since 2010, and high coverage has been sustained.

Market Segmentation:

o Based on disease indication, the market is segmented into pneumococcal, haemophilus influenza type b, diphtheria-tetanus-pertussis, meningococcal and others.
o Based on end user, the market is segmented into pediatric and adult.
o Based on countries, the Europe market is divided into EU5 and Rest of EU.

Key growth factors:

The European market will not display any extraordinary growth but average figures. Key growth factors include increasing emphasis on and availability of funds for research and development. Moreover, advancements in medical science, awareness about the availability of a higher number of vaccines for diseases will drive the growth of this market. Increasing vaccination programs by government, their initiatives, and increase in research and development activities will result in the growth of this market.

Threats and key players:

o The Europe conjugate vaccine market is expected to grow at a steady pace. The scope for significant growth is limited. Vaccine shortages are a major problem which will hinder the growth of the market. The shortage of vaccines affecting some EU/EEA Member States had direct effects on the delivery of national vaccination programmes. Since 2015, nine EU/EEA member states had to adjust their immunization policies.
o Major conjugate vaccine providers operating in the market are GlaxoSmithKline, Pfizer Inc., Merck, Novartis, Sanofi Pasteur, etc.

What’s covered in the report?

1. Overview of the Europe conjugate vaccine market
2. Market drivers and challenges in the Europe conjugate vaccine market
3. Market trends in the Europe conjugate vaccine market
4. Historical, current and forecasted market size data for Europe based on disease indication (pneumococcal, haemophilus influenza type b, diphtheria-tetanus-pertussis, meningococcal conjugate vaccines) – by revenue and by volume
5. Historical, current and forecasted market size data for Europe based on end user (pediatric and adult conjugate vaccines) – by revenue and by volume
6. Historical, current and forecasted market size data of conjugate vaccines based on countries (EU5, Rest of EU) – by revenue and by volume
7. Historical, current and forecasted market size data for country-wise segments – by revenue and by volume
8. Analysis of the competitive landscape and profiles of major companies operating in the European market

Why buy?

o Understand the demand for conjugate vaccines to determine the viability of the market
o Understand the country-specific market size and observations for each segment
o Develop strategies based on the drivers, trends and highlights for each of the segments
o Evaluate the value chain to determine the workflow and to get an idea of the current position where you are placed
o Recognize the key competitors of this market and respond accordingly
o Identify the initiatives and growth strategies taken up by the major companies and decide on the direction for further growth
o Define the competitive positioning by comparing the products and services with the key players in the market

Chapter 1: Executive Summary
1.1 Market Scope and Segmentation
1.2 Key Questions Answered in This Study
1.3 Executive Summary I
1.4 Executive Summary II

Chapter 2: Introduction
2.1. Blockchain technology-Functionality
2.2. Blockchain Application
2.3. Blockchain use cases
2.4. Value chain-Blockchain technology market

Chapter 3: Global Blockchain Technology Market overview
3.1. Overview – key observations, historical (2016-2017) and forecasted (2018-2023) market size (USD bn), geography wise market size (USD bn) in 2017
3.2. Market adoption
3.3. Market trends

Chapter 4: Blockchain Technology Market regional market overview
4.1. North America- Historical (2016-2017) and forecasted (2018-2023) market size (USD Bn), drivers, trends and challenges
4.2. Europe– Historical (2016-2017) and forecasted (2018-2023) market size (USD Bn), drivers, trends and challenges
4.3. Asia Pacific– Historical (2016-2017) and forecasted (2018-2023) market size (USD Bn), drivers, trends and challenges
4.4. Latin America– Historical (2016-2017) and forecasted (2018-2023) market size (USD Bn), drivers, trends and challenges
4.5. Middle East & Africa– Historical (2016-2017) and forecasted (2018-2023) market size (USD Bn), drivers, trends and challenges

Chapter 5: Blockchain Technology Market segmentation by industries
5.1. Global industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Industry overview, market share
5.1.1. North America industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Revenue contribution (historical and forecasted), drivers, and key competitors
5.1.2. Europe industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Revenue contribution (historical and forecasted), drivers, and key competitors
5.1.3. Asia Pacific industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Revenue contribution (historical and forecasted), drivers, and key competitors
5.1.4. Latin America industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Revenue contribution (historical and forecasted), drivers, and key competitors
5.1.5. Middle East & Africa industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Revenue contribution (historical and forecasted), drivers, and key competitors

Chapter 6: Blockchain Technology Market segmentation by type – Private, public and mixed
6.1. Market overview by type – revenue contribution, market growth, influential factors, adoption

Chapter 7: Patent Analysis
7.1. Patent Overview
7.2. Patents Filed/ Published (2012 – 2016)
7.3. Patents by Major Companies
7.4. Patents by Geographical Origin
7.5. Patents by Platform
7.6. Patents by Ledger Types
7.7. Patents by Authentication
7.8. Patents by Application types

Chapter 8: Company Profiles
8.1. Microsoft Corporation
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.2. IBM
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.3. Accenture
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.4. Deloitte
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.5. Capgemini
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.6. Cognizant
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.7. Infosys
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.8. Tata Communication Services
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.9. VirtusaPolaris
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.10. Wipro
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence

Chapter 9: Start-up Company Overview
9.1. Chain (*)
o Overview
o Key People
o Investor
o Client/Partners
o Recent Initiatives
(*) similar information is provided for all the below companies
9.2. Consensys
9.3. R3 CEV
9.4. Ripple
9.5. Guardtime
9.6. Gem
9.7. Everledger
9.8. Ascribe

Chapter 10: Conclusion
10.1. Blockchain Opportunity
10.2. Conclusion

Chapter 11: Appendix
11.1. List of Tables
11.2. Research Methodology
11.3. Assumptions
11.4. About Netscribes Inc.

The post Europe Conjugate Vaccine Market (2018-2023) first appeared on CRI Report.

The global market for conjugate vaccines will expand at a CAGR of 14.6% to reach a value of USD 100.59 Bn by 2023. Increased adoption of therapeutic vaccines for cancer, improved patient compliance, a larger product pipeline, and efforts to promote adoption of screening methods are some of the factors that will lead to the growth of the market. The Asia-Pacific market will exhibit the highest growth rate.

The vaccines are classified based on the diseases that they are target at – such as pneumococcal, haemophilus influenza type b, diphtheria-tetanus-pertussis, meningococcal, and others – and on the end users, into pediatric and adults. Technological advancements and regular vaccination programs by authorities are some of the factors that will help overcome the challenges posed by lack of awareness, shortages, uncertainty about future initiatives, and costs. Companies like GlaxoSmithKline, Pfizer Inc., Sanofi Pasteur, and Novartis are some of the major players operating in the market.

The subsequent information conveyed will be on an Excel sheet, presented in an easily identifiable format.
Chapter 1: Executive Summary
1.1 Market Scope and Segmentation
1.2 Key Questions Answered in This Study
1.3 Executive Summary I
1.4 Executive Summary II

Chapter 2: Introduction
2.1. Blockchain technology-Functionality
2.2. Blockchain Application
2.3. Blockchain use cases
2.4. Value chain-Blockchain technology market

Chapter 3: Global Blockchain Technology Market overview
3.1. Overview – key observations, historical (2016-2017) and forecasted (2018-2023) market size (USD bn), geography wise market size (USD bn) in 2017
3.2. Market adoption
3.3. Market trends

Chapter 4: Blockchain Technology Market regional market overview
4.1. North America- Historical (2016-2017) and forecasted (2018-2023) market size (USD Bn), drivers, trends and challenges
4.2. Europe– Historical (2016-2017) and forecasted (2018-2023) market size (USD Bn), drivers, trends and challenges
4.3. Asia Pacific– Historical (2016-2017) and forecasted (2018-2023) market size (USD Bn), drivers, trends and challenges
4.4. Latin America– Historical (2016-2017) and forecasted (2018-2023) market size (USD Bn), drivers, trends and challenges
4.5. Middle East & Africa– Historical (2016-2017) and forecasted (2018-2023) market size (USD Bn), drivers, trends and challenges

Chapter 5: Blockchain Technology Market segmentation by industries
5.1. Global industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Industry overview, market share
5.1.1. North America industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Revenue contribution (historical and forecasted), drivers, and key competitors
5.1.2. Europe industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Revenue contribution (historical and forecasted), drivers, and key competitors
5.1.3. Asia Pacific industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Revenue contribution (historical and forecasted), drivers, and key competitors
5.1.4. Latin America industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Revenue contribution (historical and forecasted), drivers, and key competitors
5.1.5. Middle East & Africa industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Revenue contribution (historical and forecasted), drivers, and key competitors

Chapter 6: Blockchain Technology Market segmentation by type – Private, public and mixed
6.1. Market overview by type – revenue contribution, market growth, influential factors, adoption

Chapter 7: Patent Analysis
7.1. Patent Overview
7.2. Patents Filed/ Published (2012 – 2016)
7.3. Patents by Major Companies
7.4. Patents by Geographical Origin
7.5. Patents by Platform
7.6. Patents by Ledger Types
7.7. Patents by Authentication
7.8. Patents by Application types

Chapter 8: Company Profiles
8.1. Microsoft Corporation
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.2. IBM
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.3. Accenture
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.4. Deloitte
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.5. Capgemini
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.6. Cognizant
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.7. Infosys
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.8. Tata Communication Services
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.9. VirtusaPolaris
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.10. Wipro
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence

Chapter 9: Start-up Company Overview
9.1. Chain (*)
o Overview
o Key People
o Investor
o Client/Partners
o Recent Initiatives
(*) similar information is provided for all the below companies
9.2. Consensys
9.3. R3 CEV
9.4. Ripple
9.5. Guardtime
9.6. Gem
9.7. Everledger
9.8. Ascribe

Chapter 10: Conclusion
10.1. Blockchain Opportunity
10.2. Conclusion

Chapter 11: Appendix
11.1. List of Tables
11.2. Research Methodology
11.3. Assumptions
11.4. About Netscribes Inc.

The post Data Sheet on Conjugate Vaccine Market (2018-2023) first appeared on CRI Report.

Conjugate vaccine is a type of vaccine that contains bacterial capsular polysaccharide, attached to a protein to enhance immunogenicity and protect against invasive diseases. China is one of the prominent markets with a significant growth rate for conjugate vaccines.

All Expanded Program on Immunization (EPI) vaccines (including tuberculosis, polio, measles, and diphtheria-tetanus-pertussis (DTP), hepatitis A and B, meningococcal, Japanese encephalitis, rubella and mumps) in China are free and mandatory for school admissions. Immunization clinics in China also offer non-EPI vaccines to children but for a fee (and are not covered by insurance programs), including influenza, varicella, Haemophilus influenza type B (Hib), rotavirus, and pneumococcal vaccines, among others.

Market Segmentation:

By disease indication, the market is segmented into:
o Pneumococcal
o Haemophilus influenza type B
o Diphtheria-tetanus-pertussis
o Meningococcal
o Others

By end user, the market is segmented into:
o Paediatric
o Adult

Key growth factors:

China is projected to be a significant market for conjugate vaccines during the forecast period. Rapidly increasing geriatric population, rise in consumer awareness, growing disposable income and healthcare expenditure, modernization of healthcare infrastructure, and a growing medical tourism industry will drive the growth of the conjugated vaccines market in China. According to the United Nations, China is ageing more rapidly than almost any country in recent history. This acts as a key driver for adult vaccines, owing to more demand by the geriatric population. Since the toll of pneumococcal disease in China is enormous, pneumococcal vaccination could improve children’s health and save lives and is therefore a prime selection for inclusion in the EPI schedule.

Threats and key players:

o The China conjugate vaccine market is expected to have significantly high growth. China has spent tremendous resources on the elimination of measles, but such elimination efforts should be combined with other immunization initiatives, such as educating caregivers about the benefits of other vaccines. The Chinese public is receiving more information about measles than about pneumonia or meningitis. Measles vaccine is free in Shanghai, but pneumococcal vaccine requires payment, which impacts the decision of the public significantly as they are reluctant to pay and get vaccinated.
o Major Conjugate Vaccine providers operating in the market are GlaxoSmithKline, Pfizer Inc., Merck, Novartis, Sanofi Pasteur, etc.

What’s covered in the report?

1. Overview of the China conjugate vaccine market
2. Market drivers, and challenges in the China conjugate vaccine market
3. Market trends in the China conjugate vaccine market
4. Historical, current and forecasted market size data for China based on disease indication (pneumococcal, haemophilus influenza type b, diphtheria-tetanus-pertussis, meningococcal conjugate vaccines) – by revenue and by volume
5. Historical, current and forecasted market size data for China based on end user (paediatric and adult conjugate vaccines) – by revenue and by volume
6. Analysis of the competitive landscape and profiles of major companies operating in the China market

Why buy?

o Understand the demand for conjugate vaccines to determine the viability of the market
o Develop strategies based on the drivers and trends for each of the segments
o Evaluate the value chain to determine the workflow and to get an idea of the current position where you are placed
o Recognize the key competitors of this market and respond accordingly
o Identify the initiatives and growth strategies taken up by the major companies and decide on the direction for further growth
o Define the competitive positioning by comparing the products and services with the key players in the market

Chapter 1: Executive Summary
1.1 Market Scope and Segmentation
1.2 Key Questions Answered in This Study
1.3 Executive Summary I
1.4 Executive Summary II

Chapter 2: Introduction
2.1. Blockchain technology-Functionality
2.2. Blockchain Application
2.3. Blockchain use cases
2.4. Value chain-Blockchain technology market

Chapter 3: Global Blockchain Technology Market overview
3.1. Overview – key observations, historical (2016-2017) and forecasted (2018-2023) market size (USD bn), geography wise market size (USD bn) in 2017
3.2. Market adoption
3.3. Market trends

Chapter 4: Blockchain Technology Market regional market overview
4.1. North America- Historical (2016-2017) and forecasted (2018-2023) market size (USD Bn), drivers, trends and challenges
4.2. Europe– Historical (2016-2017) and forecasted (2018-2023) market size (USD Bn), drivers, trends and challenges
4.3. Asia Pacific– Historical (2016-2017) and forecasted (2018-2023) market size (USD Bn), drivers, trends and challenges
4.4. Latin America– Historical (2016-2017) and forecasted (2018-2023) market size (USD Bn), drivers, trends and challenges
4.5. Middle East & Africa– Historical (2016-2017) and forecasted (2018-2023) market size (USD Bn), drivers, trends and challenges

Chapter 5: Blockchain Technology Market segmentation by industries
5.1. Global industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Industry overview, market share
5.1.1. North America industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Revenue contribution (historical and forecasted), drivers, and key competitors
5.1.2. Europe industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Revenue contribution (historical and forecasted), drivers, and key competitors
5.1.3. Asia Pacific industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Revenue contribution (historical and forecasted), drivers, and key competitors
5.1.4. Latin America industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Revenue contribution (historical and forecasted), drivers, and key competitors
5.1.5. Middle East & Africa industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Revenue contribution (historical and forecasted), drivers, and key competitors

Chapter 6: Blockchain Technology Market segmentation by type – Private, public and mixed
6.1. Market overview by type – revenue contribution, market growth, influential factors, adoption

Chapter 7: Patent Analysis
7.1. Patent Overview
7.2. Patents Filed/ Published (2012 – 2016)
7.3. Patents by Major Companies
7.4. Patents by Geographical Origin
7.5. Patents by Platform
7.6. Patents by Ledger Types
7.7. Patents by Authentication
7.8. Patents by Application types

Chapter 8: Company Profiles
8.1. Microsoft Corporation
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.2. IBM
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.3. Accenture
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.4. Deloitte
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.5. Capgemini
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.6. Cognizant
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.7. Infosys
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.8. Tata Communication Services
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.9. VirtusaPolaris
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.10. Wipro
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence

Chapter 9: Start-up Company Overview
9.1. Chain (*)
o Overview
o Key People
o Investor
o Client/Partners
o Recent Initiatives
(*) similar information is provided for all the below companies
9.2. Consensys
9.3. R3 CEV
9.4. Ripple
9.5. Guardtime
9.6. Gem
9.7. Everledger
9.8. Ascribe

Chapter 10: Conclusion
10.1. Blockchain Opportunity
10.2. Conclusion

Chapter 11: Appendix
11.1. List of Tables
11.2. Research Methodology
11.3. Assumptions
11.4. About Netscribes Inc.

The post China Conjugate Vaccine Market (2018-2023) first appeared on CRI Report.

Conjugate vaccine is a type of vaccine that contains bacterial capsular polysaccharide, attached with a protein to enhance immunogenicity and protect against invasive diseases. Asia Pacific is the fastest growing market for conjugate vaccines. The conjugate vaccines market in Asia-Pacific is expected to expand at a CAGR of 23.5%, leading to a revenue of USD 66.61 Bn by 2023. By volume, it is anticipated to reach 6,883.55 Million units by 2023, expanding at a CAGR of 21.87%.

A penetration rate of around 95% of DTP conjugate vaccines indicates an excellent coverage in Asia-Pacific countries and very little is left to achieve full penetration for the vaccines. Countries with high populations such as China and India, serve as major target areas for such vaccines, and the introduction of these vaccines would ensure a disease-free society.

Market Segmentation:

By disease indication, the market is segmented into:
o Pneumococcal
o Haemophilus influenza type B
o Diphtheria-tetanus-pertussis
o Meningococcal
o Others

By end user, the market is segmented into:
o Paediatric
o Adult

By countries, the Asia-Pacific market is divided into:
o China
o India
o Japan
o South Korea

Key growth factors:

The Asia Pacific has a growing market owing to improvement and advancements in medical science. Awareness about availability of higher number of vaccines as compared to before are major driving factors for the growth of this market. The primary indicators of the potential for the vaccine market are the geriatric population in Asia and its growth in some countries such as India and China. This has encouraged market participants to increase spending on research and development, and distribution facilities in Asian countries.

Threats and key players:

o The Asia-Pacific Conjugate Vaccine market is expected to grow at a significant rate. But there are issues with regard to health care access and costs. Fragmented health care has a negative impact on the effectiveness of any proposed immunization strategy. Adolescent and adult pertussis is under-recognized by lay and medical communities due to its unique clinical presentation.
o Conjugate Vaccine providers operating in the market are GlaxoSmithKline, Pfizer Inc., Merck, Novartis, Sanofi Pasteur, etc.

What’s covered in the report?

1. Overview of the Asia-Pacific conjugate vaccine market
2. Market drivers, and challenges in the Asia-Pacific conjugate vaccine market
3. Market trends in the Asia-Pacific conjugate vaccine market
4. Historical, current and forecasted market size data for the Asia-Pacific based on disease indication (pneumococcal, haemophilus influenza type b, diphtheria-tetanus-pertussis, meningococcal conjugate vaccines) – by revenue and by volume
5. Historical, current and forecasted market size data for the Asia-Pacific based on end user (paediatric and adult conjugate vaccines) – by revenue and by volume
6. Historical, current and forecasted market size data of conjugate vaccines of countries (China, India, Japan and South Korea) – by revenue and by volume
7. Historical, current and forecasted market size data for country-wise segments – by revenue and by volume
8. Analysis of the competitive landscape and profiles of major competitors operating in the Asia-Pacific market

Why buy?

o Understand the demand for conjugate vaccines to determine the viability of the market
o Understand the country-specific market size and observations for each segment
o Develop strategies based on the drivers, trends and highlights for each of the segments
o Evaluate the value chain to determine the workflow and to get an idea of the current position where you are placed
o Recognize the key competitors of this market and respond accordingly
o Identify the initiatives and growth strategies taken up by the major companies and decide on the direction of further growth
o Define the competitive positioning by comparing the products and services with the key players in the market

Chapter 1: Executive Summary
1.1 Market Scope and Segmentation
1.2 Key Questions Answered in This Study
1.3 Executive Summary I
1.4 Executive Summary II

Chapter 2: Introduction
2.1. Blockchain technology-Functionality
2.2. Blockchain Application
2.3. Blockchain use cases
2.4. Value chain-Blockchain technology market

Chapter 3: Global Blockchain Technology Market overview
3.1. Overview – key observations, historical (2016-2017) and forecasted (2018-2023) market size (USD bn), geography wise market size (USD bn) in 2017
3.2. Market adoption
3.3. Market trends

Chapter 4: Blockchain Technology Market regional market overview
4.1. North America- Historical (2016-2017) and forecasted (2018-2023) market size (USD Bn), drivers, trends and challenges
4.2. Europe– Historical (2016-2017) and forecasted (2018-2023) market size (USD Bn), drivers, trends and challenges
4.3. Asia Pacific– Historical (2016-2017) and forecasted (2018-2023) market size (USD Bn), drivers, trends and challenges
4.4. Latin America– Historical (2016-2017) and forecasted (2018-2023) market size (USD Bn), drivers, trends and challenges
4.5. Middle East & Africa– Historical (2016-2017) and forecasted (2018-2023) market size (USD Bn), drivers, trends and challenges

Chapter 5: Blockchain Technology Market segmentation by industries
5.1. Global industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Industry overview, market share
5.1.1. North America industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Revenue contribution (historical and forecasted), drivers, and key competitors
5.1.2. Europe industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Revenue contribution (historical and forecasted), drivers, and key competitors
5.1.3. Asia Pacific industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Revenue contribution (historical and forecasted), drivers, and key competitors
5.1.4. Latin America industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Revenue contribution (historical and forecasted), drivers, and key competitors
5.1.5. Middle East & Africa industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Revenue contribution (historical and forecasted), drivers, and key competitors

Chapter 6: Blockchain Technology Market segmentation by type – Private, public and mixed
6.1. Market overview by type – revenue contribution, market growth, influential factors, adoption

Chapter 7: Patent Analysis
7.1. Patent Overview
7.2. Patents Filed/ Published (2012 – 2016)
7.3. Patents by Major Companies
7.4. Patents by Geographical Origin
7.5. Patents by Platform
7.6. Patents by Ledger Types
7.7. Patents by Authentication
7.8. Patents by Application types

Chapter 8: Company Profiles
8.1. Microsoft Corporation
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.2. IBM
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.3. Accenture
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.4. Deloitte
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.5. Capgemini
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.6. Cognizant
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.7. Infosys
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.8. Tata Communication Services
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.9. VirtusaPolaris
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.10. Wipro
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence

Chapter 9: Start-up Company Overview
9.1. Chain (*)
o Overview
o Key People
o Investor
o Client/Partners
o Recent Initiatives
(*) similar information is provided for all the below companies
9.2. Consensys
9.3. R3 CEV
9.4. Ripple
9.5. Guardtime
9.6. Gem
9.7. Everledger
9.8. Ascribe

Chapter 10: Conclusion
10.1. Blockchain Opportunity
10.2. Conclusion

Chapter 11: Appendix
11.1. List of Tables
11.2. Research Methodology
11.3. Assumptions
11.4. About Netscribes Inc.

The post Asia-Pacific Conjugate Vaccine Market (2018-2023) first appeared on CRI Report.